[Report on interferon treatment in chronic hepatitis. Office of the General Deputy Director of Benefits and Evaluation of Health Technologies. Office of the General Director of Insurance and Health Planning].
D000328:Adult; D002648:Child; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000628:therapy; D006526:Hepatitis C / Q000628:therapy; D003699:Hepatitis D / Q000628:therapy; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D013997:Time Factors
D007372:Interferons